Clinical trial
Effect of Genetics on Metabolism of Efavirenz
NCT00245986 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00245986 |
|---|---|
| Title | Effect of Genetics on Metabolism of Efavirenz |
| Official title | Pharmacogenetics of Efavirenz Metabolism: Association of CYP2B6 Genotype and Prolonged Drug Exposure |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolism |
| Intervention type | Procedure |
| Interventions | Blood draw |
| Enrollment | 350 |
| Start date | Oct 18, 2005 |
| Completion | May 20, 2008 |
| First posted | Oct 28, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: